Mms Holdings Inc. Unveils Redesigned Website

CANTON, Mich. - Nov. 16, 2015 - PRLog -- Canton, MI — Today MMS Holdings Inc. announced the launch of a new, redesigned version of its website, www.mmsholdings.com. Key features of the site include a cleaner and more attractive design, more engaging user experience with enhanced search and navigation, optimization for mobile devices, and quick and intuitive access to its versatile platform.

According to Prasad Koppolu, Vice President for MMS Holdings Inc., “These enhancements will ensure a superior and informative user experience. Development and creation of the new content has taken several months to complete, but we feel the new application-driven content will help guide visitors to the solutions best suited for their needs.”

Other website features include:

· Convenient forms to request more information;

·Additional white papers and technical pieces, along with an expanded list of industry-specific solutions;

· A drop down menu with information on Regulatory Submissions, Clinical Development and Monitoring, Trial Disclosures, Medical Writing Services, Data Management, Biometrics and Statistical Programming, and Pharmacovigilance;

· Company news and events, including a schedule of tradeshow participation across the globe;

·Seamless integration of social media platforms;

· A blog updating visitors on the latest happenings within MMS Holdings and the larger CRO industry, and

·An employment portal accessing the many worldwide job opportunities.

“Our goal was to design a user-friendly site and make it as seamless as possible to navigate,” said Kelly Hill, Director of Project and Account Management. “We not only completely redesigned the MMS Holdings Website, but also our brand. We want to showcase the MMS Holdings Inc. website as a true reflection of our organization and our employees, a fresh, innovative and contemporary company with a depth of expertise in the pharmaceutical, biotech, and medical device industries.”

-30-

About MMS Holdings Inc.

MMS Holdings Inc. is a growing clinical research organization (CRO) that focuses on regulatory submission support for the pharmaceutical, biotech and medical device industries. Our strong industry experience and scientific approach to drug development makes us a valuable partner in creating compelling submissions that meet rigorous regulatory standards. Our clients span from top 10 pharma to virtual biotechs, and we support each one with the same standard of excellence. Our core service areas include medical and regulatory writing, biostatistics, clinical programming, data management, clinical development, clinical trial disclosure, regulatory affairs, regulatory submissions and pharmacovigilance. Our mission is to deliver high-quality services, rooted in good science and decades of regulatory experience, that will assist our clients in developing and marketing life-changing therapies, thereby positively affecting patient’s lives worldwide.